ClinicalTrials.Veeva

Menu

Validation of a Preclinical Model Based on Patient-derived Organoids for the Study of the Gut-joint Axis in Spondyloarthritis (ORGANOSPA)

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

Spondyloarthritis
Inflammatory Bowel Diseases

Treatments

Procedure: Synovial ultrasound-guided biopsy Intestinal biopsy

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This project aims to develop and validate a model of human organoids derived from patients with Spondyloarthritis, focusing on synovial and intestinal tissues as targets of the gut-joint axis. The tissue marker profile of patient-derived organoids studied by gene expression, immunohistochemistry, and cytokine production profile will be compared with that of controls in order to test for the presence of specific biomarkers.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • More than 18 years of age;
  • Ability to understand and sign an informed consent form;
  • Clinical indication for intestinal and/or synovial biopsy;
  • Only for SpA patients group: meeting ASAS classification criteria.

Exclusion criteria

  • Actively treated cancer;
  • Severe comorbidities that, in the investigator's opinion, may affect the quality of samples for planned experimental applications;
  • Only for patients undergoing ileal-colic biopsy: history of colorectal cancer disease, celiac disease;
  • Only for patients undergoing a synovial biopsy: septic arthritis.

Trial contacts and locations

1

Loading...

Central trial contact

Gerlando Natalello, Dr; Maria Antonietta D'Agostino, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems